Tumorigenicity assessment of human cell-processed therapeutic products-Reference-Cited by-同舟云学术

Tumorigenicity assessment of human cell-processed therapeutic products

Published:2015-09 Issue:5 Volume:43 Page:416-421
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Yasuda Satoshi,Sato Yoji

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference17 articles.

1. Embryonic stem cell trials for macular degeneration: a preliminary report;Schwartz;Lancet,2012

2. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies;Schwartz;Lancet,2015

3. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies;Hentze;Stem Cell Res,2009

4. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks;World Health Organization,2013

5. Following the development of a CD4 T cell response in vivo: from activation to memory formation;Garcia;Immunity,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells;Stem Cells Translational Medicine;2024-02-07

2. Label-free palindromic DNA nanospheres as naked-eye colorimetric assay platform for detection of telomerase activity;Talanta;2023-02

3. Stability and biosafety of human epidermal stem cell for wound repair: preclinical evaluation;Stem Cell Research & Therapy;2023-01-05

4. Label-free and high-throughput removal of residual undifferentiated cells from iPSC-derived spinal-cord progenitor cells;2022-12-19

5. Principles and Protocols For Post-Cryopreservation Quality Evaluation of Stem Cells in Novel Biomedicine;Frontiers in Pharmacology;2022-05-03